The animal vaccine market size was valued at USD 12 billion in 2025 and is projected to grow from USD 13 billion in 2026 to USD 21 billion by 2034 at a CAGR of 6% during the forecast period (2026-2034). North America dominated the animal vaccine market with a market share of 38.5% in 2025.
Animal vaccines are biological products used to protect livestock, poultry, and companion animals from infectious diseases by strengthening their immune systems. They help reduce disease outbreaks, improve animal health, and support safe food production. Demand is growing due to increasing awareness of animal welfare, rising livestock production, expanding pet ownership, and the need to prevent the spread of zoonotic diseases.
Download a Free Sample To learn more about this report,
Growing Focus on Preventive Healthcare in Livestock and Companion Animals
Animal Vaccine Market trends are being driven by the growing importance of disease prevention in both livestock and companion animals. Governments, veterinarians, and livestock producers are increasing vaccination programs to reduce the spread of infectious diseases, improve animal welfare, and protect food production. Rising concerns over zoonotic diseases and antimicrobial resistance are also encouraging preventive healthcare instead of relying heavily on antibiotics. In addition, growing pet ownership is increasing demand for routine vaccination against diseases such as rabies, parvovirus, and feline leukemia. These factors are supporting animal vaccine market growth as preventive veterinary care becomes a higher priority worldwide.
Rising Innovation in mRNA Vaccines and Advanced Veterinary Biotechnology
Animal Vaccine Market trends are also being influenced by rapid advances in veterinary biotechnology and next-generation vaccine platforms. Companies are investing in recombinant, DNA-based, and mRNA vaccine technologies to develop safer vaccines with stronger and longer-lasting immune responses. Researchers are also focusing on combination vaccines that protect against multiple diseases with a single dose, helping reduce stress on animals and improve vaccination efficiency. These innovations are strengthening animal vaccine market share as veterinary healthcare providers adopt more advanced immunization solutions for livestock, poultry, aquaculture, and companion animals.
Rising Animal Disease Outbreaks and Focus on Preventive Healthcare
The animal vaccine market is growing steadily as livestock farmers and pet owners become more focused on preventing infectious diseases before they spread. Vaccines are widely used to protect cattle, poultry, swine, dogs, cats, and other animals from viral and bacterial infections. The increasing risk of diseases such as avian influenza, foot-and-mouth disease, rabies, and swine infections is strengthening animal vaccine market demand. Growing livestock production and government vaccination programs are also encouraging wider use of preventive animal healthcare.
High Vaccine Development Costs and Storage Requirements
The animal vaccine market faces challenges because developing and testing new vaccines requires significant investment, long research periods, and strict regulatory approvals. Many vaccines also require controlled temperatures during transportation and storage, which can be difficult in rural areas with limited cold-chain infrastructure. These factors can increase distribution costs and restrict vaccine availability in some developing regions.
Development of Advanced and Next-Generation Vaccines
The animal vaccine market offers strong opportunities as companies invest in recombinant vaccines, DNA vaccines, vector-based vaccines, and other advanced technologies. These products can provide better disease protection and help farmers manage emerging animal health risks. The growing pet population and increasing spending on companion animal healthcare are also creating new opportunities. Continued innovation in vaccine technology is expected to strengthen animal vaccine market share across livestock and companion animal applications.
Managing Emerging Diseases and Maintaining Vaccine Effectiveness
The animal vaccine market continues to face challenges as new disease strains emerge and existing pathogens change over time. Vaccine manufacturers need to regularly monitor disease patterns and update products to maintain effective protection. At the same time, differences in animal species, farming conditions, and vaccination practices can affect vaccine performance. Improving disease surveillance, farmer awareness, and access to veterinary services will remain important for long-term market growth.
Request Customizationto receive a tailored report.
Attenuated Vaccines Segment Dominated the Market with 27.8% Share in 2025
The attenuated vaccines segment dominated the global animal vaccine market with a 27.8% share in 2025. These vaccines are widely used because they provide strong and long-lasting immunity with fewer doses. They are commonly used to protect both livestock and companion animals from infectious diseases, helping farmers and pet owners reduce disease outbreaks and improve animal health.
The inactivated vaccines, subunit vaccines, and recombinant vaccines segments are also growing steadily. Inactivated vaccines remain a trusted option because of their strong safety profile, while subunit vaccines are gaining popularity for their targeted immune response. Recombinant vaccines are seeing higher demand as advances in biotechnology improve vaccine effectiveness and disease prevention.
The toxoid vaccines, conjugate vaccines, and DNA vaccines segments are also expanding. Toxoid and conjugate vaccines continue to be used for specific bacterial infections, while DNA vaccines are attracting attention because of their potential to provide faster vaccine development and improved protection against emerging animal diseases.
Livestock Animal Segment Dominated the Market with 57.6% Share in 2025
The livestock animal segment dominated the global animal vaccine market with a 57.6% share in 2025. Vaccination plays an important role in protecting cattle, poultry, swine, and other farm animals from infectious diseases that can affect productivity and food supply. Growing demand for safe animal products and better livestock health management continues to drive this segment.
The companion animal segment is also growing steadily as pet owners become more aware of preventive healthcare and routine vaccination. Rising pet ownership, increasing spending on veterinary care, and better access to advanced vaccines are supporting demand for dogs, cats, and other companion animals.
The aquaculture segment is expanding at a healthy pace as fish farming continues to grow worldwide. Vaccination is becoming an important tool for preventing disease outbreaks, improving fish survival rates, and reducing the use of antibiotics, supporting the long-term growth of this segment.
Speak to an Analystto discuss market opportunities.
North America animal vaccine market accounted for 38.5% of the global market, reaching USD 4.62 billion in 2025, and is projected to grow at a CAGR of 6.8% during the forecast period. The market is growing steadily because of increasing awareness of animal health, rising livestock production, and higher pet ownership. Farmers and pet owners are focusing more on disease prevention, while governments continue to support vaccination programs for animals.
The U.S. market was valued at USD 3.93 billion in 2025, making it the largest contributor in North America. Strong demand for livestock and companion animal vaccines, advanced veterinary healthcare services, and continuous investment in animal health research are driving market growth.
Canada's market reached USD 0.69 billion in 2025. Growing livestock farming, increasing pet adoption, and greater awareness of preventive animal healthcare continue to support steady market growth.
Europe animal vaccine market accounted for 28.4% of the global market, reaching USD 3.41 billion in 2025, and is expected to register a CAGR of 6.5% during the forecast period. Rising demand for safe animal products, strict regulations on animal health, and increasing vaccination programs are supporting market growth. The region is also investing in better veterinary services and disease control initiatives.
Germany's market accounted for USD 0.99 billion in 2025. A strong veterinary healthcare system, growing livestock industry, and increasing focus on disease prevention continue to support market growth.
The UK market was valued at USD 0.68 billion in 2025. Rising pet ownership, increasing awareness of animal welfare, and expanding vaccination programs continue to contribute to market growth.
Asia Pacific animal vaccine market accounted for 22.6% of the global market, valued at USD 2.71 billion in 2025, and is projected to register a CAGR of 8.9% during the forecast period. Growing demand for meat and dairy products, expanding livestock production, and increasing government efforts to control animal diseases are driving market growth. Rising investment in veterinary healthcare is also creating new opportunities across the region.
Japan's market generated USD 0.49 billion in 2025. High standards for animal healthcare, increasing pet ownership, and growing demand for advanced veterinary vaccines continue to support market growth.
China's market accounted for USD 1.41 billion in 2025, representing the largest share within Asia Pacific. The country's large livestock population, expanding veterinary infrastructure, and increasing focus on disease prevention continue to drive market growth.
Latin America animal vaccine market accounted for 6.3% of the global market, reaching USD 0.76 billion in 2025, and is projected to grow at a CAGR of 7.4% during the forecast period. Rising livestock production, increasing exports of animal products, and growing awareness of animal disease prevention are supporting market growth across the region.
Brazil's market reached USD 0.39 billion in 2025. As one of the world's leading livestock producers, the country continues to invest in vaccination programs and better veterinary healthcare to improve animal productivity.
Middle East & Africa animal vaccine market accounted for 4.2% of the global market, totaling USD 0.50 billion in 2025, and is anticipated to grow at a CAGR of 6.9% during the forecast period. Growing livestock farming, improving veterinary services, and increasing government efforts to control infectious animal diseases are supporting market growth across the region.
The UAE market was valued at USD 0.18 billion in 2025. Rising investment in livestock health, growing demand for quality veterinary care, and increasing awareness of preventive vaccination continue to support market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Associate
Mitiksha Koul is a Research Associate with 2 years of experience in market research. She focuses on analyzing industry trends, competitive landscapes, and growth opportunities to support strategic decision-making. Mitiksha’s strong analytical skills and research expertise enable her to deliver actionable insights that help businesses adapt to evolving market dynamics and achieve sustainable growth.
We are featured on:
sales@straitsresearch.com